                         SEQUENCE LISTING

<110>  Institut d'Investigacions Biomdiques August Pi i Sunyer
       Consejo Superior de Investigaciones Cientficas
 
<120>  Use of the soluble form of AXL in the diagnosis and/or prognosis 
       of heart failure syndrome

<130>  P2159PC00

<150>  EP 12382048
<151>  2012-02-13

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  426
<212>  PRT
<213>  Homo sapiens

<400>  1

Ala Pro Arg Gly Thr Gln Ala Glu Glu Ser Pro Phe Val Gly Asn Pro 
1               5                   10                  15      


Gly Asn Ile Thr Gly Ala Arg Gly Leu Thr Gly Thr Leu Arg Cys Gln 
            20                  25                  30          


Leu Gln Val Gln Gly Glu Pro Pro Glu Val His Trp Leu Arg Asp Gly 
        35                  40                  45              


Gln Ile Leu Glu Leu Ala Asp Ser Thr Gln Thr Gln Val Pro Leu Gly 
    50                  55                  60                  


Glu Asp Glu Gln Asp Asp Trp Ile Val Val Ser Gln Leu Arg Ile Thr 
65                  70                  75                  80  


Ser Leu Gln Leu Ser Asp Thr Gly Gln Tyr Gln Cys Leu Val Phe Leu 
                85                  90                  95      


Gly His Gln Thr Phe Val Ser Gln Pro Gly Tyr Val Gly Leu Glu Gly 
            100                 105                 110         


Leu Pro Tyr Phe Leu Glu Glu Pro Glu Asp Arg Thr Val Ala Ala Asn 
        115                 120                 125             


Thr Pro Phe Asn Leu Ser Cys Gln Ala Gln Gly Pro Pro Glu Pro Val 
    130                 135                 140                 


Asp Leu Leu Trp Leu Gln Asp Ala Val Pro Leu Ala Thr Ala Pro Gly 
145                 150                 155                 160 


His Gly Pro Gln Arg Ser Leu His Val Pro Gly Leu Asn Lys Thr Ser 
                165                 170                 175     


Ser Phe Ser Cys Glu Ala His Asn Ala Lys Gly Val Thr Thr Ser Arg 
            180                 185                 190         


Thr Ala Thr Ile Thr Val Leu Pro Gln Gln Pro Arg Asn Leu His Leu 
        195                 200                 205             


Val Ser Arg Gln Pro Thr Glu Leu Glu Val Ala Trp Thr Pro Gly Leu 
    210                 215                 220                 


Ser Gly Ile Tyr Pro Leu Thr His Cys Thr Leu Gln Ala Val Leu Ser 
225                 230                 235                 240 


Asn Asp Gly Met Gly Ile Gln Ala Gly Glu Pro Asp Pro Pro Glu Glu 
                245                 250                 255     


Pro Leu Thr Ser Gln Ala Ser Val Pro Pro His Gln Leu Arg Leu Gly 
            260                 265                 270         


Ser Leu His Pro His Thr Pro Tyr His Ile Arg Val Ala Cys Thr Ser 
        275                 280                 285             


Ser Gln Gly Pro Ser Ser Trp Thr His Trp Leu Pro Val Glu Thr Pro 
    290                 295                 300                 


Glu Gly Val Pro Leu Gly Pro Pro Glu Asn Ile Ser Ala Thr Arg Asn 
305                 310                 315                 320 


Gly Ser Gln Ala Phe Val His Trp Gln Glu Pro Arg Ala Pro Leu Gln 
                325                 330                 335     


Gly Thr Leu Leu Gly Tyr Arg Leu Ala Tyr Gln Gly Gln Asp Thr Pro 
            340                 345                 350         


Glu Val Leu Met Asp Ile Gly Leu Arg Gln Glu Val Thr Leu Glu Leu 
        355                 360                 365             


Gln Gly Asp Gly Ser Val Ser Asn Leu Thr Val Cys Val Ala Ala Tyr 
    370                 375                 380                 


Thr Ala Ala Gly Asp Gly Pro Trp Ser Leu Pro Val Pro Leu Glu Ala 
385                 390                 395                 400 


Trp Arg Pro Gly Gln Ala Gln Pro Val His Gln Leu Val Lys Glu Pro 
                405                 410                 415     


Ser Thr Pro Ala Phe Ser Trp Pro Trp Trp 
            420                 425     


